Iodixanol Versus Low-Osmolar Contrast Media for Prevention of Contrast Induced Nephropathy: Meta-analysis of Randomized, Controlled Trials
暂无分享,去创建一个
Furman S. McDonald | S. Cha | C. Rihal | F. McDonald | B. Bartholmai | A. From | F. A. Al Badarin | Aaron M. From
[1] Charles Davidson,et al. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. , 2009, American heart journal.
[2] A. Kastrati,et al. Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention , 2009, Circulation. Cardiovascular interventions.
[3] H. Gurm,et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. , 2009, JACC. Cardiovascular interventions.
[4] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[5] P. Teirstein,et al. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. , 2009, JACC. Cardiovascular interventions.
[6] Kuender D Yang,et al. Comparison of Iodixanol and Iohexol in Patients Undergoing Intravenous Pyelography: A Prospective Controlled Study , 2009, Renal failure.
[7] D. Leung,et al. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N‐acetylcysteine and hydration before coronary angiography and intervention: a randomized trial , 2009, Internal medicine journal.
[8] W. Bautz,et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.
[9] Yu-jie Zhou,et al. A prospective, double‐blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[10] Furman S. McDonald,et al. Mortality associated with nephropathy after radiographic contrast exposure. , 2008, Mayo Clinic proceedings.
[11] W. Laskey,et al. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. , 2008, American heart journal.
[12] U. Schoepf,et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. , 2008, Radiology.
[13] E. V. van Beek,et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. , 2008, AJR. American journal of roentgenology.
[14] R. Robbs,et al. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. , 2008, Journal of diabetes and its complications.
[15] H. Thomsen,et al. The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients With Chronic Kidney Disease Undergoing Abdominal Computed Tomography , 2008, Investigative radiology.
[16] A. Lerman,et al. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. , 2008, Journal of the American College of Cardiology.
[17] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[18] B. Meier,et al. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection. , 2007, International journal of cardiology.
[19] A. Colombo,et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.
[20] R. Erbel,et al. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. , 2006, Clinical nephrology.
[21] Gilles Soulez,et al. Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Computed Tomography: A Double-Blind Comparison of Iodixanol and Iopamidol , 2006, Investigative radiology.
[22] F. Veglia,et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. , 2006, The New England journal of medicine.
[23] C. Becker,et al. Contrast medium use. , 2006, The American journal of cardiology.
[24] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.
[25] J. Brinker,et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.
[26] T. Fehr,et al. Contrast nephropathy: review focusing on prevention. , 2004, Journal of the American College of Cardiology.
[27] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[28] R. Fischbach,et al. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial , 2004, European Radiology.
[29] Sven-Göran Fransson,et al. Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.
[30] Douglas G Altman,et al. Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.
[31] Kirk N. Garratt,et al. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.
[32] J. Muhlestein,et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. , 2000, Circulation.
[33] M. Bertrand,et al. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Tr , 2000, Circulation.
[34] N. Chalmers,et al. Comparison of iodixanol and iohexol in renal impairment. , 1999, The British journal of radiology.
[35] M. Cova,et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial , 1998, European Radiology.
[36] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[37] J. Thornbury,et al. A randomized comparison of iodixanol and iohexol in adult body computed tomography scanning. , 1996, Academic radiology.
[38] W. Nemzek,et al. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography. , 1996, Academic radiology.
[39] R. Grossman,et al. A randomized comparison of iodixanol and iohexol in adult intracranial computed tomography scanning. , 1996, Academic radiology.
[40] E. Siegel,et al. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial. , 1996, Academic radiology.
[41] E. Siegel,et al. Iodixanol and ioxaglate in adult aortography and peripheral arteriography: a phase III clinical trial. , 1996, Academic radiology.
[42] J. O. Nossen,et al. A comparison of iodixanol with iopamidol in aorto-femoral angiography. , 1995, The British journal of radiology.
[43] J. Jakobsen. Renal Effects of Iodixanol in Healthy Volunteers and Patients with Severe Renal Failure , 1995, Acta radiologica. Supplementum.
[44] W. Kou,et al. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. , 1994, The American journal of cardiology.
[45] B. Bolstad,et al. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. , 1993, Clinical radiology.
[46] B. Bolstad,et al. Iodixanol in Abdominal Digital Subtraction Angiography , 1993, Acta radiologica.
[47] N. Pugh,et al. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. , 1993, Clinical radiology.
[48] K. Endresen,et al. Iodixanol in Cardioangiography in Patients with Coronary Artery Disease , 1993, Acta radiologica.
[49] D. Kristoffersen,et al. Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media. , 1992, European journal of radiology.
[50] P. Parfrey,et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.
[51] W. G. Cochran. The combination of estimates from different experiments. , 1954 .